Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 – 2022
- Published Date: Feb 2018
- Pages: 75
- Format: PDF
- Report ID: PM1106
- Base Year: 2016
- Historical Data: 2015-2016
Table of Contents
- Dermatology Overview
- Key Indications in Dermatology Drugs Market Therapy Area
- Atopic Dermatitis Overview
- Psoriasis Overview
- Acne Overview
- Rosacea Overview
- Diagnosis Patterns
- Dermatology- Fragmented Market with Several Opportunities
- Epidemiology-Prevalent Population & Segmentations
- Atopic Dermatitis-Prevalent Population (2016-2022)
- Psoriasis-Prevalent Population (2016-2022)
- Acne-Prevalent Population (2016-2022)
- Rosacea-Prevalent Population (2016-2022)
- Treatment Patterns and Treatment Algorithms in Dermatology Therapeutic Area
- Atopic Dermatitis-Treatment Practices
- Psoriasis-Treatment Practices
- Acne-Prevalent Treatment Practices
- Rosacea-Treatment Practices
- Market Forecast by Therapeutic Area (2016-2022)
- Atopic Dermatitis- Market Forecast (2016-2022)
- Psoriasis- Market Forecast (2016-2022)
- Acne- Market Forecast (2016-2022)
- Rosacea- Market Forecast (2016-2022)
- Marketed Drugs and Sales Forecast (2016-2022)
- Atopic Dermatitis Key Drugs Market Forecast
- dupilumab (Dupixent)-Sanofi-Sales forecast 2016-2022
- Nemolizumab-Galderma-Sales forecast 2016-2022
- Tralokinumab- LEO Pharma-Sales forecast 2016-2022
- Crisaborole (Eucrisa)-Pfizer-Sales forecast 2016-2022
- RVT-501-Roviant Sciences-Sales forecast 2016-2022
- OPA-15406- Otsuka Pharmaceuticals-Sales forecast 2016-2022
- Psoriasis Key Drugs Market Forecast
- etanercept; Enbrel-Sales forecast 2016-2022
- infliximab; Remicade-Sales forecast 2016-2022
- adalimumab; Humira-Sales forecast 2016-2022
- ustekinumab; Stelara-Sales forecast 2016-2022
- secukinumab;Cosentyx-Sales预测2016 - 2022
- ixekizumab; Taltz-Sales forecast 2016-2022
- golimumab; Simponi-Sales forecast 2016-2022
- brodalumab; Siliq-Sales forecast 2016-2022
- guselkamab; Tremfya-Sales forecast 2016-2022
- Acne Key Drugs Market Forecast
- Acne Topical Drugs Market Sales & Share 2016-2022
- Acne Oral Drugs Market Sales & Share 2016-2022
- 酒渣鼻关键药物市场预测
- Acne Topical Drugs Market Sales & Share 2016-2022
- Acne Oral Antibiotics Market Sales & Share 2016-2022
- Market Forecast by Regions (2016-2022)
- North America- Market Forecast (2016-2022)
- Europe- Market Forecast (2016-2022)
- APAC-Market Forecast (2016-2022)
- ROW- Market Forecast (2016-2022)
- Factors Driving the Market of Dermatology Drugs
- Factors Restraining the Market of Dermatology Drugs
- About Polaris Market Research
- Disclaimer
- Sales Support
Suggested Report
- Thyroid Cancer Diagnostics Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Liver Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Astaxanthin Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Circulating Tumor Cells Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- CBD Nutraceuticals Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok